JAZZJazz Pharmaceuticals plc · Insider ownership research

Jazz Pharmaceuticals plc insiders sold $69.8M in the past 12 months. How much of their stake is that?

Insiders sold $69.8M in the past 12 months.48% was sold under disclosed trading plans, 2% to cover taxes, 51% with no plan disclosed. The largest seller, Bruce Cozadd (Director), sold $27.8M. 63% of these sales were shares from exercising options.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026

$35.3M

sold with no plan disclosed, past 12 months

48%

of sales were under disclosed trading plans, past 12 months

11 of 20

officers and directors sold shares, past 12 months

Is this normal? More than usual: about 4x the 5-year average. 11 insiders sold; the average is 11 a year. Year by year

Latest filing: Filed Oct 7 for a sale on Oct 6. Renee Gala sold 2K shares ($473K) under a disclosed plan. Filing

SEC ownership filings: 85 filed in the 12 months to Oct 13, 2026; 1,269 on record since May 31, 2007 · See the evidence

What stands out

Six insiders sold $34.3M with no disclosed plan: Bruce Cozadd ($17.0M), Neena Patil ($10.7M) and Patricia Carr ($2.2M), plus 3 more. The filings don't state a reason.Bruce Cozadd: largest such sale, Nov 26, 2025 · Neena Patil: largest such sale, Feb 26, 2026 · Patricia Carr: largest such sale, Nov 18, 2025

A share of stake is shown for 0 of the 11 officers and directors who sold. 20 are left out

i

Left out: Seamus Mulligan, Bruce Cozadd, Renee Gala, Robert Iannone, Philip Johnson, Neena Patil, Samantha Pearce, Kenneth O'Keefe, Mary Henderson, Patrick Enright, Heather McSharry, Norbert Riedel, Anne ORiordan, Rick Winningham, Jennifer Cook, Mark Smith, Patrick Kennedy, Patricia Carr, Laura Hamill and Ted Love (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Bruce Cozadd

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$27.8M39% planned 61% no plan disclosed

Robert Iannone

EVP, Global Head of R&D & CMO

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$20.4MDisclosed plan

Neena Patil

EVP & Chief Legal Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$11.5M7% planned 93% no plan disclosed

Patricia Carr

SVP, Chief Accounting Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$2.5M10% to cover taxes 90% no plan disclosed

Rick Winningham

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.7MNo plan disclosed

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

Oct 6, 2026Renee Gala sold 2K shares ($473K) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Renee Gala President & CEO, Director	2,000	$236.40	n/a	n/a	Oct 6, 2026	Oct 7, 2026

Oct 1, 2026Bruce Cozadd sold 6K shares ($1.4M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Bruce Cozadd Director	6,000	$230.33	n/a	n/a	Oct 1, 2026	Oct 5, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Outside holders, reported separately

Kenneth O'Keefe reported no open-market sales in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Common questions

Is the Jazz Pharmaceuticals plc CEO selling stock?

Yes. Renee Gala sold 4K shares ($959K) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Jazz Pharmaceuticals plc insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 48% of sales by value ran under 10b5-1 trading plans disclosed in the filings, 2% were to cover taxes and 51% had no disclosed plan. A trading plan schedules sales in advance.

Are any Jazz Pharmaceuticals plc insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold11 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Bruce Cozadd Director	$27.8M 144K shares	Not confirmed share of stake is being verified. Why	39% under a disclosed plan 61% no plan disclosed
Robert Iannone EVP, Global Head of R&D & CMO	$20.4M 84K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Neena Patil EVP & Chief Legal Officer	$11.5M 59K shares	Not confirmed share of stake is being verified. Why	7% under a disclosed plan 93% no plan disclosed
Patricia Carr SVP, Chief Accounting Officer	$2.5M 14K shares	Not confirmed share of stake is being verified. Why	10% to cover taxes 90% no plan disclosed
Rick Winningham Director	$1.7M 8.2K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Samantha Pearce EVP, Chief Commercial Officer	$1.6M 6.9K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Mary Henderson SVP, Technical Operations	$1.4M 7.6K shares	Not confirmed share of stake is being verified. Why	73% to cover taxes 27% no plan disclosed
Heather McSharry Director	$1.1M 5.4K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Renee Gala President & CEO, Director	$959K 4K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Norbert Riedel Director	$656K 3.4K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Mark Smith Director	$267K 1.2K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Board members representing outside shareholders, reported separately: Kenneth O'Keefe. Details

The full ownership picture0 of 20 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider	Held Oct 13, 2025	Sold	Held Oct 13, 2026	Still held
Seamus Mulligan ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Seamus Mulligan are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Seamus Mulligan Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Seamus Mulligan are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)
Bruce Cozadd ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Bruce Cozadd are complete. Director	n/a	−144K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Bruce Cozadd Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Bruce Cozadd are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −34Kwithheld by the company for taxes
Renee Gala ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Renee Gala are complete. President & CEO, Director	n/a	−4K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Renee Gala Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Renee Gala are complete; balances and unit counts will be added when the check is finished. −600gifted (net of own trusts) −19Kwithheld by the company for taxes
Robert Iannone ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Robert Iannone are complete. EVP, Global Head of R&D & CMO	n/a	−84K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Robert Iannone Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Robert Iannone are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −14Kwithheld by the company for taxes
Philip Johnson ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Philip Johnson are complete. EVP & Chief Financial Officer	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Philip Johnson Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Philip Johnson are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −6Kwithheld by the company for taxes
Neena Patil ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Neena Patil are complete. EVP & Chief Legal Officer	n/a	−59K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Neena Patil Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Neena Patil are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −7.7Kwithheld by the company for taxes
Samantha Pearce ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Samantha Pearce are complete. EVP, Chief Commercial Officer	n/a	−6.9K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Samantha Pearce Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Samantha Pearce are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −7.4Kwithheld by the company for taxes
Kenneth O'Keefe ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kenneth O'Keefe are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Kenneth O'Keefe Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kenneth O'Keefe are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −603withheld by the company for taxes
Mary Henderson ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mary Henderson are complete. SVP, Technical Operations	n/a	−7.6K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Mary Henderson Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mary Henderson are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −4.9Kwithheld by the company for taxes
Patrick Enright ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patrick Enright are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Patrick Enright Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Enright are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Heather McSharry ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Heather McSharry are complete. Director	n/a	−5.4K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Heather McSharry Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Heather McSharry are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.9Kwithheld by the company for taxes
Norbert Riedel ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Norbert Riedel are complete. Director	n/a	−3.4K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Norbert Riedel Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Norbert Riedel are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Anne ORiordan ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Anne ORiordan are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Anne ORiordan Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anne ORiordan are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)
Rick Winningham ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Rick Winningham are complete. Director	n/a	−8.2K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Rick Winningham Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Rick Winningham are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Jennifer Cook ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jennifer Cook are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Jennifer Cook Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jennifer Cook are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Mark Smith ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mark Smith are complete. Director	n/a	−1.2K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Mark Smith Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mark Smith are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Patrick Kennedy ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patrick Kennedy are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Patrick Kennedy Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Kennedy are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.9Kwithheld by the company for taxes
Patricia Carr ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patricia Carr are complete. SVP, Chief Accounting Officer	n/a	−14K	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Patricia Carr Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patricia Carr are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.4Kwithheld by the company for taxes
Laura Hamill ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Laura Hamill are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Laura Hamill Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Laura Hamill are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes
Ted Love ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Ted Love are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Ted Love Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ted Love are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −743withheld by the company for taxes

Holdings and share of stake for Jazz Pharmaceuticals plc are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$69.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $69.8M across 337,124 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $33.2M · 48%

52%

The lighter segment is sales with no plan disclosed in the filing ($36.6M), including tax-related sales outside a plan.

No plan disclosed · $35.3M

Sales with no 10b5-1 plan and no tax reference in the filing. $17.0M of it is Bruce Cozadd. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Bruce Cozadd, Nov 26, 2025

Taxes

$1.3M of sales (1.8%) cite tax obligations in their footnotes. Separately, 109,903 shares ($22.3M) were withheld by the company for taxes, which isn't a market sale. Example: Patricia Carr, Feb 26, 2026

Charitable gifts · 600 shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Bruce Cozadd Director	144K	$27.8M	39%	40%	Nov 18, 2025 to Oct 1, 2026
Robert Iannone EVP, Global Head of R&D & CMO	84K	$20.4M	100%	29%	Nov 17, 2025 to Aug 27, 2026
Neena Patil EVP & Chief Legal Officer	59K	$11.5M	7%	16%	Feb 26, 2026 to Sep 10, 2026
Patricia Carr SVP, Chief Accounting Officer	14K	$2.5M	0%	4%	Nov 18, 2025 to Mar 9, 2026
Rick Winningham Director	8.2K	$1.7M	0%	2%	Nov 18, 2025 to May 22, 2026
Samantha Pearce EVP, Chief Commercial Officer	6.9K	$1.6M	0%	2%	May 28, 2026 to May 28, 2026
Mary Henderson SVP, Technical Operations	7.6K	$1.4M	0%	2%	Dec 9, 2025 to Feb 26, 2026
Heather McSharry Director	5.4K	$1.1M	0%	2%	Nov 20, 2025 to May 22, 2026
Renee Gala President & CEO, Director	4K	$959K	100%	1%	Sep 8, 2026 to Oct 6, 2026
Norbert Riedel Director	3.4K	$656K	0%	0.9%	Feb 27, 2026 to Feb 27, 2026
Mark Smith Director	1.2K	$267K	100%	0.4%	Jun 15, 2026 to Jun 15, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$20.8M	$1.2M	$0	$19.6M
Dec 2025	$1.2M	$0	$0	$1.2M
Jan 2026	$0	$0	$0	$0
Feb 2026	$12.8M	$0	$1.3M	$11.5M
Mar 2026	$1.4M	$1.1M	$0	$235K
Apr 2026	$1.1M	$1.1M	$0	$0
May 2026	$4.3M	$1.5M	$0	$2.8M
Jun 2026	$2.0M	$2.0M	$0	$0
Jul 2026	$1.4M	$1.4M	$0	$0
Aug 2026	$20.7M	$20.7M	$0	$0
Sep 2026	$2.3M	$2.3M	$0	$0
Oct 2026	$1.9M	$1.9M	$0	$0

Board members representing outside shareholders (1)Listed and sourced; not part of the management totals or the answer line

Directors whose reported holdings sit mostly in an investment fund or a corporate shareholder they represent, not in their own name, with beneficial ownership disclaimed except for their own financial interest. Listed and sourced here; not part of the management totals or the answer line. Shares a fund hands to its own investors are distributions, not sales.

Board member	Held Oct 13, 2025	Sold	Held Oct 13, 2026	Still held
Kenneth O'Keefe ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kenneth O'Keefe are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Kenneth O'Keefe Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kenneth O'Keefe are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 4x the 5-year average. 11 insiders sold; the average is 11 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 13, 2026 Latest 12 months	337K	11	$69.8M
Oct 13, 2025 1 year earlier	54K	4	$7.2M
Oct 13, 2024 2 years earlier	11K	5	$1.3M
Oct 14, 2023 3 years earlier	60K	18	$8.7M
Oct 14, 2022 4 years earlier	204K	17	$29.9M
Oct 14, 2021 5 years earlier	102K	12	$16.1M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty20 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Jazz Pharmaceuticals plc are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,269 filings on record, 85 filed in the 12-month period, and how we read them

All 1,269 Forms 3, 4 and 5 on record for Jazz Pharmaceuticals plc (SEC CIK 1232524), filed from May 31, 2007 to Oct 7, 2026; 85 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (43)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Catherine Sohn	Aug 15, 2023	14,868 shares, last reported balance as of Aug 14, 2023
Peter Gray	Aug 15, 2023	16,068 shares, last reported balance as of Aug 14, 2023
Kim Sablich	Jun 7, 2023	28,478 shares, last reported balance as of Jun 5, 2023
Daniel Swisher Jr.	Mar 7, 2023	55,014 shares, last reported balance as of Mar 5, 2023
Finbar Larkin	Mar 7, 2023	21,779 shares, last reported balance as of Mar 7, 2023
Christopher Tovey	Jul 7, 2022	14,663 shares, last reported balance as of Jul 5, 2022
Paul Berns	Aug 9, 2021	8,290 shares, last reported balance as of Aug 5, 2021
Elmar Schnee	Aug 9, 2021	8,270 shares, last reported balance as of Aug 5, 2021
Michael Miller	Mar 13, 2020	22,118 shares, last reported balance as of Mar 12, 2020
Paul Treacy	Aug 14, 2019	16,524 shares, last reported balance as of Aug 12, 2019
Karen Wilson	Mar 7, 2019	18,385 shares, last reported balance as of Mar 5, 2019
Matthew Young	Mar 7, 2019	36,200 shares, last reported balance as of Mar 6, 2019
Iain McGill	Mar 7, 2019	24,938 shares, last reported balance as of Mar 5, 2019
Suzanne Hooper	Feb 27, 2019	39,738 shares, last reported balance as of Feb 27, 2019
Karen Smith	Mar 7, 2018	28,474 shares, last reported balance as of Mar 5, 2018
Russell Cox	Dec 13, 2017	102,821 shares, last reported balance as of Dec 11, 2017
Jeffrey Tobias	Mar 9, 2015	38,484 shares, last reported balance as of Mar 5, 2015
Fintan Keegan	Jul 10, 2014	31,750 shares, last reported balance as of Jul 8, 2014
Kathryn Falberg	Mar 6, 2014	133,387 shares, last reported balance as of Mar 5, 2014
James Momtazee	Aug 14, 2013	31,200 shares, last reported balance as of Aug 13, 2013
Michael Michelson	Mar 12, 2013	13,885 shares, last reported balance as of Jan 11, 2012
Michael Michelson	Mar 12, 2013	44,333 shares, last reported balance as of Mar 8, 2013
Alan Sebulsky	Mar 13, 2012	54,355 shares, last reported balance as of Mar 9, 2012
Bryan Cressey	Mar 13, 2012	76,694 shares, last reported balance as of Mar 9, 2012
Carol Gamble	Mar 13, 2012	32,213 shares, last reported balance as of Mar 9, 2012
Bryan Cressey	Mar 13, 2012	5,856,202 shares, last reported balance as of Mar 9, 2012
Samuel Colella	Jan 13, 2012	1,272,508 shares, last reported balance as of Jan 11, 2012
Samuel Colella	Jan 13, 2012	1,530,183 shares, last reported balance as of Jan 11, 2012
Michael DesJardin	Aug 15, 2011	14,574 shares, last reported balance as of Aug 13, 2011
Mark Eller	Aug 15, 2011	4,151 shares, last reported balance as of Aug 13, 2011
Janne Wissel	Jun 2, 2011	48,544 shares, last reported balance as of May 31, 2011
Nathaniel Zilkha	Mar 14, 2011	No balance on record
Robert Myers	Dec 2, 2010	156,898 shares, last reported balance as of Nov 30, 2010
Joan Colligan	Dec 2, 2010	14,424 shares, last reported balance as of Nov 30, 2010
James Tananbaum	Aug 27, 2010	No balance on record
James Tananbaum	Aug 27, 2010	1,424,495 shares, last reported balance as of Jul 21, 2008
Samuel Saks	Jan 23, 2009	358,868 shares, last reported balance as of Nov 28, 2008
Matthew Fust	Dec 1, 2008	58,948 shares, last reported balance as of Nov 28, 2008
Alexander Albert	Aug 19, 2008	No balance on record
Paul Raether	Jul 22, 2008	9,942,946 shares, last reported balance as of Jul 21, 2008
William Janetschek	May 2, 2008	8,577,974 shares, last reported balance as of Apr 24, 2008
BRIDGER MANAGEMENT LLC	Apr 16, 2008	2,667,050 shares, last reported balance as of Apr 14, 2008
Patel Jaimin	Aug 17, 2007	No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.